StockWatch
·

Arihant Superstructures Limited Q2 FY27 Results

ARIHANTSUPQ2 FY27 Results
Filing
Result:Poor· Market: Up#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Cut

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue133.221.2%8.6%
Total Income134.691.2%8.8%
Expenditure120.790.4%9.3%
PBT13.918.3%4.0%
Net Profit10.557.9%6.0%
OPM20.99%0.05pp3.43pp
NPM7.83%0.48pp0.21pp
EPS1.5612.2%10.6%
View full financials

Revenue (core metric for real estate) grew only 8.6% YoY while PAT growth trailed at 6% on a 342bps OPM compression from an unfavorable project mix, and the quarter still tracks well below original FY27 guidance.

ARIHANTSUP · Q2 FY-2027 · THE VERDICT

Margin collapse and presales stall recast Q2 from growth to warning

Revenue grew 8.6% YoY as guided, but EBITDA margins crashed 640 basis points, presales fell 27%, and management cut guidance on both absolute revenue and profitability. The call exposed structural headwinds — cost inflation and affordability pressure — that prior optimism masked.

10 Nov 2026 · 6 min read
H1 EBITDA Margin

20.97%

vs 27.44% prior year, −640 bps

Presales Units (Q2)

236

vs 280 Q2 FY26, −27% YoY

Gross Margin

36%

vs 43% prior year, −700 bps

FY27 Guidance

₹640 Cr implied

vs ₹700 Cr prior, −8.5% cut

The quarter in one sentence

Arihant delivered headline revenue growth of 8.6% YoY, holding its Q2 target — but the underlying picture is a company pressed by cost inflation (raw materials +22% YoY) and affordability headwinds (presales down 27% despite 'steady demand' narrative). EBITDA margins fell 640 basis points; management cut full-year guidance on both revenue (₹700 Cr → ~₹640 Cr implied) and profitability (30–35% EBITDA target → 25%); and withdrew the 2,500-unit FY27 delivery target without replacement. The call tone was candid on cost pressure but defensive on presales. The market's verdict: down 2.9% day 1 of the result announcement.

Claims on the call vs. what holds up

Management's key assertions and how they square with the data

Q2 revenue ₹133 Cr, 9% YoY growth

What the numbers show

Delivered ₹133.2 Cr, +8.6% YoY

Verdict

Supported (within rounding)

Presales down due to planned inventory depletion; launches lined up Q3–Q4

What the numbers show

236 units Q2 vs 280 in Q2 FY26 (−27%); H1 457 units means H2 must deliver 2,043 to hit 2,500 target — 4.5x the H1 pace. Launches not yet confirmed.

Verdict

Partial (factually true on inventory, but H2 recovery unproven)

H1 margin compression (20.97% vs 27.44%) due to project mix and 4–5% cost inflation

What the numbers show

Raw material costs up 22% YoY; only 4–5% of total construction cost built in. Gross margin fell 700 bps (43%→36%); gap between 22% input inflation and 4–5% total cost absorption suggests selective mitigation, not full pass-through.

Verdict

Overstated (mix is real, but cost control explanation incomplete)

FY27 revenue +20% growth

What the numbers show

Prior guidance ₹700 Cr; new guidance '20% growth' on H1 base (~₹265 Cr) implies ₹636–₹640 Cr full-year

Verdict

Contradicted (is a downgrade from ₹700 Cr, framed as growth to obscure miss)

EBITDA margins target 25%+ for full year FY27

What the numbers show

Prior guidance was 30–35% once premium projects scale; new target 25%+ on full-year basis

Verdict

Contradicted (target lowered by 500–1,000 bps, not highlighted as revision)

What changed on this call

  • FY27 revenue target revised down from ₹700 Cr to ~₹640 Cr (−₹60 Cr, −8.5%)

  • EBITDA margin guidance narrowed: 30–35% residential target → 25%+ full-year (downgrade not disclosed)

  • 2,500-unit delivery target for FY27 withdrawn; not reaffirmed despite being core prior guidance

  • Hospitality PAT quantum (prior ₹50 Cr+ by year 3–4) now vague: 'annuity from FY30 onwards' with no number

  • Debt cost refinancing progressing: STCI debt replaced ICICI at 8.6% vs 11.75%; blended cost 13% → target 12.5% by FY27 end

  • Presales momentum stalled: 236 units Q2 vs 280 Q2 FY26 (−27% YoY), blamed on inventory depletion

How the market reacted and where the stock stands

The result announcement triggered a −2.9% move on day 1 (delivery 18.5%), which faded slightly to −0.81% by day 3. The stock is now trading at ₹218, down 60.62% from its all-time high of ₹553.6, though up 15.47% from its 52-week low of ₹188.8. Relative to key moving averages, the stock sits below the SMA50 (₹223.87) and well below the SMA200 (₹248.74), signalling bearish technicals; RSI at 50.8 remains neutral (not oversold). Volume trend is normal — no capitulation selling, but also no institutional bids to catch the knife.

Ownership has remained frozen: FII at 0.18%, DII at 0.00%, promoter at 71.10% — no material change over the last four quarters. The lack of FII/DII engagement and the static promoter stake suggest the stock is being avoided by institutions on execution concerns, not shorted on fundamentals. The market's 60% drawdown from ATH reflects deep skepticism on near-term earnings recovery and execution credibility, and the result reaction (−2.9% day 1) confirms that presales decline and margin compression landed worse than a flat-to-slightly-positive read.

The bull case

The long-term project pipeline is real and materially sized. World Villas Phase 1 (178 villas, ₹12 billion GDV) has landed 60 pre-sales to date — proof of concept on luxury demand. Town Villas (99.5 acres, 58 lakh sq ft saleable, ₹4,800 Cr GDV) is fully land-consolidated and in municipal approvals; launch timing is FY28, with a multi-year presales runway. ITC Hotels Mementos partnership is signed (227 rooms + 44 suites, 3-year construction from Q3 FY27 start = revenue FY29, annuity from FY30+) — a concrete, funded deal with a blue-chip partner, not a concept. Collections remain strong (₹316 Cr H1, ₹154.5 Cr Q2), showing buyer commitment on delivered/near-delivery projects. Debt refinancing is on track (STCI debt at 8.6% vs prior 11.75%); blended cost target of 12.5% by FY27 end signals pressure relief ahead. Operating cash flow has turned positive for the first time in years.

The bear case

Presales fell 27% YoY despite management's claim of 'steady demand.' The Q2 number (236 units) is down 56 units YoY; H1 cumulative is 457 units. To hit the 2,500 FY27 target, H2 must deliver ~2,043 units — a 4.5x acceleration from H1 pace, unconfirmed by any new launch GDVs or presales traction signals. Gross margin collapsed 700 basis points (43% to 36%); management pins this on 'project mix,' but raw material costs are up 22% YoY and only 4–5% total construction cost increase has been factored in — a gap that suggests selective hedging or under-pricing on some projects, not pure mix correction. Interest rate headwinds are mounting: 25–50 basis points of additional hikes are expected; the affordable segment (< ₹50 lakh) is showing stress, with discretionary spending consuming disposable incomes. Net debt stands at ₹827 Cr with ₹435 Cr of unsecured loans; leverage is high (1.75x net debt / net worth) and refinancing is not guaranteed if rates stay elevated. Large execution risks loom: Town Villas approvals are 'still under progress' and launch has been pushed to FY28 (6+ month slip from prior guidance); redevelopment JVs have been 'on the verge of signing' for over 6 months with multi-party complexity unresolved. All revenue from hotel and Club 10 Gymkhana is pushed to FY29+ — a 2+ year wait. Geographic concentration at 95% MMR with minimal diversification outside Jodhpur leaves zero hedging against regional demand shocks.

Ranked risks for a holder

Risks ordered by how much they should concern an existing shareholder

Presales momentum broken; H2 recovery unproven

High

27% YoY presales decline is not 'planned inventory depletion' — it signals demand softness or pricing resistance. H2 must deliver 2,043 units (4.5x H1) for target to hold; unconfirmed by any new project launches. If H2 achieves <1,200 units, 2,500 FY27 target is missed and confidence in recovery erodes further.

Margin compression masks cost control issues

High

700 bps gross margin fall (43%→36%) plus 640 bps EBITDA decline (27.4%→21% H1) are structural, not cyclical. Raw material inflation 22% YoY but only 4–5% total cost built in suggests gap, not full mitigation. Until margins stabilize above 40% gross, bottom-line growth will lag revenue.

Interest rate hike + affordability pressure

Medium

25–50 bps additional rate hikes expected; affordable segment already under stress. First-time buyer discretionary spend is redirected to other purchases. Mid-income segment ('good absorption' per mgmt) may hold, but at lower volumes. Presales decline may deepen if rates rise further.

High leverage + refinancing execution risk

Medium

₹827 Cr net debt with ₹435 Cr unsecured = 1.75x leverage. Blended cost 13% today, target 12.5% by FY27 end assumes successful refinancing; if rates stay high and refinancing stalls, finance cost will not improve and PAT headroom shrinks.

Execution delays on large projects

Medium

Town Villas approvals pending, launch pushed to FY28. Redevelopment JVs 'on verge' of signing for 6+ months. ITC hotel revenue to FY29, annuity to FY30+. Any slip in approvals or multi-party deal closure delays runway and RoE on capex.

Geographic concentration (95% MMR)

Low

No geographic hedging outside Jodhpur. Regional demand shocks or policy changes in MMR have outsized impact. Jodhpur remains small and 'steady' only.

The debate

The honest read: Arihant is a quality mid-sized franchise with a genuinely strong long-term project slate and signed partnerships. BUT near-term execution is visibly faltering. Presales momentum is broken (−27% YoY is not noise), margins are under structural pressure (cost inflation outpacing built-in mitigation), guidance has been cut silently (revenue ₹700 Cr → ~₹640 Cr, margins 30–35% → 25%), and execution timelines are slipping (Town Villas FY28, redevelopment deals still 'on verge'). The stock's 60% drawdown and −2.9% result reaction reflect institutional skepticism, not panic — but the burden is now squarely on management to prove Q3–Q4 presales can reverse the 27% YoY decline and H2 can deliver 2,043 units to save the year. Until that reversal lands, the stock will stay beaten down. This is not a broken franchise, but it is a stalled execution story wearing long-term upside disguise.

What to watch next

The three things that will resolve the debate by end of Q3/Q4
  • 1 · Q3 presales traction — units and bookings value

    Do Q3–Q4 launches (Panvel project, planned inventory work completions) drive presales recovery from 236 Q2 units? Need >500 units per quarter to stay on 2,500-unit pace. If presales remain <300 units in Q3, the FY27 target is unachievable and confidence in near-term recovery will shatter.

  • 2 · Gross margin stabilization and cost mitigation

    Does gross margin recover to >40% by Q3–Q4, or stay below 40%? This is the leading indicator for whether management can pass through cost inflation via pricing on unsold inventory or if affordability pressure forces margin concessions. If margin stays <40%, EBITDA target of 25%+ is unreachable.

  • 3 · Town Villas and redevelopment JV closures

    Are approvals for Town Villas and Chowk municipal clearances granted in H2 FY27? Do redevelopment JV signatures land by Q3 as promised, or slip again? Any slip extends the next presales catalyst and signals execution risk on other projects.

Arihant Superstructures is not a broken story — its long-term projects (World Villas, Town Villas, ITC hotel) are real and well-scoped. But Q2 exposed that near-term execution is under pressure. Presales have stalled (−27% YoY), margins are compressed 640 bps, guidance has been quietly cut, and large projects are delayed. The market has repriced the stock down 60% from ATH, and the −2.9% result reaction confirms that institutions are waiting for proof that the company can arrest presales decline and stabilize margins before re-engaging. The stock is no longer 'cheap' on near-term metrics — it is 'repriced for risk.' The number to track is Q3 presales units; if H2 can't achieve >1,500 units across both quarters, the 2,500 FY27 target is a miss and the narrative flips from 'temporary headwind' to 'stalled growth.' Until that's proven, hold on cautious conviction. The upside is there if execution lands, but the downside from here — if presales slip further or margins compress another 200–300 bps — is material.

Informational and educational content only. Not investment advice.